Making disease, making citizens: The politics of Hepatitis C

Making Disease, Making Citizens: The Politics of Hepatitis C

Volumn , Issue , 2013, Pages 1-168

  Fraser, Suzanne ^a   Seear, Kate ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84937409259     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (224)

1. Ahmed, S. 2004a. Collective feelings, or the impressions left by others. Theory, Culture & Society, 21(2), 25-42.
2. Ahmed, S. 2004b. The Cultural Politics of Emotion. Edinburgh: Edinburgh University Press.
3. Alter, H.J. 1991. Descartes before the horse: I clone, therefore I am: The hepatitis C virus in current perspective. Annals of Internal Medicine, 115(8), 644-9.
4. Altman, D. 1986. AIDS and the New Puritanism. Sydney: Pluto Press.
5. Anti-Discrimination Board of NSW. 2001. C-change: Report of the Enquiry into Hepatitis C Related Discrimination. Sydney: Anti-Discrimination Board of NSW.
6. Appelbaum, D. 1995. The Stop. Albany, NY: SUNY Press.
7. Ariss, R. 1997. Against Death: The Practice of Living with AIDS. Amsterdam: Gordon and Breach.
8. Armstrong, D. 1984. The patient's view. Social Science and Medicine, 18, 737-44.
9. Aronowitz, R. 1998. Making Sense of Illness: Science, Society and Disease. Cambridge: Cambridge University Press.
10. Australian Gastroenterology Institute. 1991. Hepatitis C: An Information Leaflet for Patients and Interested Members of the General Public. Sydney: AGI.
11. Australian Injecting and Illicit Drug Users League. 2009. Inside Out. ACT: AIVL.
12. Ballard, K. and Elston, M.A. 2005. Medicalisation: A multidimensional concept. Social Theory & Health, 3, 228-41.
13. Barad, K. 1998. Getting real: Technoscientific practices and the materialization of reality. Differences: A Journal of Feminist Cultural Studies, 10(2), 87-128.
14. Barad, K. 2001. Reconfiguring space, time, and matter, in Feminist Locations: Global and Local, Theory and Practice, edited by M. Dekoven. New Brunswick, NJ and London: Rutgers University Press, 75-109.
15. Barad, K. 2003. Posthumanist performativity: Toward an understanding of how matter comes to matter. Signs: Journal of Women in Culture and Society, 28(3), 801-31.
16. Barad, K. 2007. Meeting the Universe Halfway: Quantum Physics and the Entanglement of Matter and Meaning, Durham, NC: Duke University Press.
17. Bhandari, B.N. and Wright, T.L. 1995. Hepatitis C: An overview. Annual Review of Medicine, 46, 309-17.
18. Blackman, L. 2006. Inventing the psychological: Lifestyle magazines and the fiction of autonomous self, in Media and Cultural Theory, edited by J. Curran and D. Morley. London: Routledge, 209-32.
19. Bland, J.M. and Altman, D.G. 1996. Measurement error. British Medical Journal. 21: 313(7059), 744.
20. Blumenberg, H. 1987. The Genesis of the Copernican World. Cambridge, MA: MIT Press.
21. Bonkovsky, H.L. and Mehta, S. 2001. Hepatitis C: A review and update. Disease-a-Month, 47(12), 610-64.
22. Bourdieu, P. 1986. The forms of capital, translated by R. Nice, in Handbook for Theory and Research for the Sociology of Education edited by J.G. Richardson. New York: Greenword Press, 241-58.
23. Bowen, D. and Walker, C. 2005. The origin of quasispecies: Cause or consequence of chronic hepatitis C viral infection? Journal of Hepatology, 42, 408-17.
24. Brook, H. and Stringer, R. 2005. Users, using, used: A beginner's guide to deconstructing drugs discourse. International Journal of Drug Policy, 16(5), 316-25.
25. Brownscombe, J. 2004. The uppers and downers of medicalising addiction. studentBMJ, 12, 89-132.
26. Bruce, C. and Montanarelli, L. 2007. Hepatitis C: The First Year, 2nd edition. New York: Marlowe & Company.
27. Brunsdon, C. 1987. Feminism and soap opera, in Out of Focus, edited by K. Davies, J. Dickey and T. Stratford. London: The Women's Press, 147-50.
28. Bunton, R. 1992. More than a woolly jumper: Health promotion as social regulation. Critical Public Health, 3(2), 4-11.
29. Bunton, R. and Burrows, R. 1995. Consumption and health in the ‘epidemiological’ clinic of late modern medicine, in The Sociology of Health Promotion: Critical Analyses of Consumption, Lifestyle and Risk, edited by R. Bunton, S. Nettleton and R. Burrows. London: Routledge, 206-22.
30. Bunton, R., Nettleton, S. and Burrows, R. 1995 (eds). The Sociology of Health Promotion: Critical Analyses of Consumption, Lifestyle and Risk. London: Routledge.
31. Burchell, G. 1996. Liberal government and techniques of the self, in Foucault and Political Reason: Liberalism, Neo-liberalism and Rationalities of Government, edited by A. Barry, T. Osborne and N. Rose. Chicago: University of Chicago Press, 19-36.
32. Bury, M. 1997. Health and Illness in a Changing Society. London: Routledge.
33. Butler, J. 1990. Gender Trouble: Feminism and the Subversion of Identity. New York and London: Routledge.
34. Butler, J. 1993. Bodies that Matter: On the Discursive Limits of Sex. New York and London: Routledge.
35. Butt, G. 2008. Stigma in the context of hepatitis C: Concept analysis. Journal of Advanced Nursing, 62(6), 712-24.
36. Carey, J. 2006. Waging war on hepatitis C. Bloomberg Businessweek [Online, 21 February]. Available at: http://www.businessweek.com/technology/content/feb2006/tc20060221_196821.htm [accessed: 7 August 2010].
37. Carey, W.D. and Patel, G. 1992. Viral hepatitis in the 1990s, part III: Hepatitis C, hepatitis E, and other viruses (review). Cleveland Journal of Medicine, 595-601.
38. Castel, R. 1991. From dangerousness to risk, in The Foucault Effect: Studies in Governmentality, edited by G. Burchell, C. Gordon and P. Miller. Chicago: University of Chicago Press, 281-97.
39. Cherry, S. 2008. The ontology of a self-help book: A paradox of its own existence. Social Semiotics, 18(3), 337-48.
40. Cichocki, M. 2009. Living with HIV: A Patient's Guide. Jefferson, NC: McFarland & Co.
41. Cohen, M.R., Gish, R.G. and Doner, K. 2007. The Hepatitis C Help Book: A Groundbreaking Treatment Program Combining Western and Eastern Medicine for Maximum Wellness and Healing. New York: St. Martin's Press.
42. Colquhoun, S.D. 1996. Hepatitis C: A clinical update. Archives of Surgery, 131, 18-23.
43. Commonwealth of Australia Department of Health and Ageing. 2005. National Hepatitis C Strategy 2005-2008. Canberra: Department of Health and Ageing.
44. Commonwealth of Australia Department of Health and Ageing. 2008. National Hepatitis C Resource Manual. Canberra: Department of Health and Ageing.
45. Conrad, P. and Schneider, A.W. 1980a. Deviance and Medicalisation: From Badness to Sickness, 1st edition. St Louis, MO: Mosby.
46. Conrad, P. and Schneider, A.W. 1980b. Looking at levels of medicalisation: A comment on Strong's critique of the thesis of medical imperialism. Social Science & Medicine. 14A, 75-9.
47. Davis, G. 1999. Hepatitis C virus genotypes and quasispecies. The American Journal of Medicine, 107(6B), 21s-6s.
48. Davis, M. and Rhodes, T. 2004. Managing seen and unseen blood associated with drug injecting: Implications for theorising harm reduction for viral risk. International Journal of Drug Policy, 15, 377-84.
49. Daykin, N. and Naidoo, J. 1995. Feminist Critiques of health promotion, in The Sociology of Health Promotion: Critical Analyses of Consumption, Lifestyle and Risk, edited by R. Bunton, S. Nettleton and R. Burrows. London: Routledge, 59-69.
50. Deleuze, G. 1994. Difference and Repetition. London: Athlone Press.
51. Deleuze, G. and Guattari, F. 1987. A Thousand Plateaus: Capitalism and Schizophrenia, translated by Brian Massumi. Minneapolis: University of Minnesota Press.
52. Derrida, J. 1978. Writing and Difference. Chicago: University of Chicago Press.
53. Dieperink, E., Ho, S.B., Thuras, P. and Willenbring, M.L. 2003. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics, 44(2), 104-12.
54. Dieperink, E., Willenbring, M. and Ho, S.B. 2000. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. American Journal of Psychiatry, 157, 867-76.
55. Dodge, Y. 2003. The Oxford Dictionary of Statistical Terms, 6th edition. Oxford: Oxford University Press.
56. Dolan, M. 1999. The Hepatitis C Handbook. Berkeley, CA: North Atlantic Books.
57. Dowsett, G. 1996. Practicing Desire: Homosexual Sex in the Era of AIDS. Stanford: Stanford University Press.
58. Duffin, J. 2005. Lovers and Livers: Disease Concepts in History. Toronto: University of Toronto Press.
59. Dwyer, R., Fraser, S. and Treloar, C. 2011. Doing things together? Analysis of health promotion materials to inform hepatitis C prevention among couples. Addiction Research & Theory, 19(4), 352-61.
60. Everson, G. and Weinberg, H. 1998-2006. Living with Hepatitis C: A Survivor's Guide. New York: Hatherleigh Press.
61. Forns, X., Bukh, J. and Purcell, R.H. 2002. Review: The challenge of developing a vaccine against hepatitis C virus. Journal of Hepatology, 37, 684-95.
62. Foucault, M. 1973. The Birth ofthe Clinic: The Archaeology ofMedical Perception. London: Tavistock.
63. Foucault, M. 1977-1995. Discipline and Punish. Harmondsworth: Penguin.
64. Foucault, M. 1980a. Body/power, in Power/knowledge: Selected Interviews and Other Writings 1972-1977, edited by C. Gordon. New York: Random House, 55-62.
65. Foucault, M. 1980b. Two lectures, in Power/knowledge: Selected Interviews and Other Writings 1972-1977, edited by C. Gordon. New York: Random House, 78-108.
66. Foucault, M. 1980c. Power and strategies, in Power/knowledge: Selected Interviews and Other Writings 1972-1977, edited by C. Gordon. New York: Random House, 134-45.
67. Foucault, M. 1984. Truth and power, in The Foucault Reader, edited by P. Rabinow. New York: Random House, 50-69.
68. Foucault, M. 1994. The subject and power, in Essential Works of Foucault 1954-1984, Volume 3: Power, edited by J.D. Faubion. London: Penguin, 326-48.
69. Frank, C., Mohamed, M., Strickland, G., Lavanchy, D., Arthur, R., Magder, L., Khoby, T., Abdel-Wahab, Y, Ohn, E. and Anwar, W. 2000. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet, 355(9207), 887-91.
70. Fraser, N. 1981. Foucault on modern power: Empirical insights and normative confusions. Praxis International, 1(3), 272-87.
71. Fraser, S. 2003. Cosmetic Surgery, Gender and Culture. Basingstoke: Palgrave.
72. Fraser, S. 2004. ‘It's Your Life!’: Injecting drug users, individual responsibility and hepatitis C prevention. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 8(2), 199-221.
73. Fraser, S. 2011. Beyond the ‘potsherd’: The role of injecting drug use-related stigma in shaping hepatitis C, in The Drug Effect: Health, Crime and Society, edited by S. Fraser and D. Moore. Melbourne: Cambridge University Press.
74. Fraser, S. and Moore, D. 2011. Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment. Addiction Research & Theory.
75. Fraser, S. and Treloar, C. 2006. ‘Spoiled identity’ in hepatitis C infection: The binary logic of despair. Critical Public Health, 16, 99-110.
76. Fraser, S. and Valentine, K. 2008. Substance and Substitution: Methadone Subjects in Liberal Societies. Basingstoke: Palgrave.
77. Fried, M.W. 2002. Side effects of therapy of hepatitis C and their management. Hepatology, 36, S237-S244.
78. Fried, M.W., Shiffman, M.L., Reddy, K.R., Smith, C., Marinos, G., Goncales, F.L., Haussinger, D., Diago, M., Carosi, G., Dhumeaux, D., Craxi, A., Lin, A., Hoffman, J., Yu, J. 2002. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New England Journal of Medicine, 347, 975-82.
79. Fung, S.K and Lok, A.SF. 2005. Update on viral hepatitis in 2004. Current Opinion in Gastroenterology, 21(3), 300-307.
80. Fyfe, G. and Law, J. 1988. On the invisibility of the visual: Editors’ introduction, in Picturing Power: Visual Depiction and Social Relations, edited by G. Fyfe and J. Law. London: Routledge, 1-14.
81. Galvin, R. 2002. Disturbing notions of chronic illness and individual responsibility: Towards a genealogy of morals. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 6(2), 107-37.
82. Goode, E. and Ben-Yehuda, N. 1994. Moral panics: Culture, politics and social construction. Annual Review of Sociology, 20, 149-71.
83. Gutfreund, K.S. and Bain, V.G. 2000. Chronic viral hepatitis C: Management update. Canadian Medical Association Journal, 162(6), 827-33.
84. Hadziyannis, S.J., Sette, H., Morgan, T.R., Balan, V., Diago, M., Marcellin, P., Ramadori, G., Bodenheimer, H., Bernstein, D., Rizzetto, M., Zeuzem, S., Pockros, P.J., Lin, A., Ackrill, A.M. 2004. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Annals of Internal Medicine, 140, 346-55.
85. Hall, S. 1996. On Postmodernism and articulation: An interview with Stuart Hall, in Stuart Hall: Critical Dialogues in Cultural Studies, edited by D. Morley and K. Chen. London and New York: Routledge, 131-50.
86. Haraway, D. 1992. The promises of monsters: A regenerative politics for inappropriate/d others, in Cultural Studies, edited by L. Grossberg, C. Nelson and P. Treichler. London and New York: Routledge, 295-337.
87. Harris, M. 2005. Living with hepatitis C: The medical encounter. New Zealand Sociology, 20(1), 4-19.
88. Hartsock, N. 1990. Foucault on power: A theory for women, in Feminism/Postmodernism, edited by L. Nicholson. London: Routledge, 157-73.
89. Harvey, A.J and Harvey, K.G. 2008. The hazards of blood transfusion in historical perspective. Blood, 112(7), 2617-26.
90. Hazleden, R. 2003. Love yourself: The relationship of the self with itself in popular self-help texts. Journal of Sociology, 39(4), 413-28.
91. Hazleden, R. 2009. Promises of peace and passion: Enthusing the readers of self help. M/C Journal [Online], 12(2). Available at: http://journal.media-culture. org.au/index.php/mcjournal/article/view/124 [accessed: 27 January 2011].
92. Hellard, M., Sacks-Davis, R., Higgs, P., Bharadwaj, M., Bowden, D., Drummer, H. and Aitken, C. 2010. Elispot testing shows very few injecting drug users avoid hepatitis C virus exposure. Poster presented to the International Liver Congress 2010, Vienna, Austria, 14-18 April. Abstract available at: www.kenes.com/easl2010/Posters/Abstract951.htm [accessed: 13 June 2010].
93. Hepatitis Australia. 2007. Contact: Post-test Information for Hepatitis C. ACT: Hepatitis Australia.
94. Hepatitis C Council NSW. 2009. Transmission Magazine. 2nd Edition, June. Darlinghurst: HCC NSW.
95. Hepatitis C Support Project. 2008. A Guide to Hepatitis C Treatment Side Effect Management. [Online: Hepatitis C Support Project]. Available at http://www. hcvadvocate.org/hepatitis/factsheets_pdf/Treatment_Side_effect_Guide.pdf [accessed 13 May 2010].
96. Hopwood, M. 2009. Recovery from Hepatitis C Treatments. (Monograph 6/2009). Sydney: National Centre in HIV Social Research.
97. Hopwood, M. and Southgate, E. 2003. Living with hepatitis C: A sociological review. Critical Public Health, 13(3), 251-67.
98. Hopwood, M. and Treloar, C. 2003. The 3-D Project: Diagnosis, Disclosure, Discrimination and Living with Hepatitis C. NCHSR Monograph, No. 6, National Centre in HIV Social Research. Kensington: University of New South Wales.
99. Hopwood, M. and Treloar, C. 2005. The experience of interferon-based treatments for hepatitis C infection. Qualitative Health Research, 15(5), 635-46.
100. Hopwood, M. and Treloar, C. 2007. Pretreatment preparation and management of interferon-based therapy for hepatitis C virus infection. Journal of Advanced Nursing, 59(3), 248-54.
101. Hoy, D. 1986. Power, repression, progress: Foucault, Lukes and the Frankfurt School, in Foucault: A Critical Reader edited by D.C. Hoy. Oxford: Basil Blackwell, 123-47.
102. Hughes, C.A and Shafran, S.D. 2006. Chronic hepatitis C virus management: 2000-2005 update. The Annals of Pharmacotherapy, 40, 74-82.
103. Hulse, G. 1997. Australia's public health response to HIV and HCV: A role for ‘affected’ communities. Drug and Alcohol Review, 16, 171-6.
104. Hunt, C.M., Dominitz, J.A., Bute, B.P., Waters, B., Blasi, U. and Williams, D.M. 1997. Effect of interferon - a treatment of chronic hepatitis C on health-related quality of life. Digestive Diseases and Sciences. 42(12), 2482-6.
105. Hunt, P. and de Luna, W. 2007. Reading livers through reading literature: HEPATOSCOPY and HARUSPICY in Iliad [Online]. Available at: http://traumwerk.stanford.edu/archaeolog/2007/09/reading_livers_through_reading_1.html [accessed: 11 March 2010].
106. Hwang, SJ. 2001. Hepatitis C Virus: an overview. Journal of Microbiological and Immunological Infection, 34, 227-34.
107. Illich, I. 1976. Medical Nemesis. New York: Pantheon Books.
108. Keane, H. 2002. What's Wrong with Addiction? Carlton South: Melbourne University Press.
109. Keating, G.M. and Curran, M.P. 2003. Peginterferon alpha-2a (40Kd) plus ribavirin: A review of its use in the management of chronic hepatitis C. Drugs and Society, 63(7), 701-30.
110. Körner, H. 2010. Negotiating treatment for hepatitis C: Interpersonal alignment in the clinical encounter. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 14(3), 272-91.
111. Kraus, M.R., Schaefer, A., Csef, H., Scheurlen, M. and Faller, H. 2000. Emotional state, coping styles and somatic variables in patients with chronic hepatitis C. Psychosomatics, 41, 377-84.
112. Krug, G. 1995. Hepatitis C: Discursive domains and epistemic chasms. Journal of Contemporary Ethnography, 24(3), 299-323.
113. Krug, G. 1997. HCV in the mass media: An unbearable absence of meaning, in Cultural Studies: A Research Annual. Vol. 2, edited by N. Denzin. Greenwich, CT and London: Jai Press, 91-108.
114. Kuhn, T.S. 1957. The Copernican Revolution. Planetary Astronomy in the Development of Western Thought. Cambridge, MA: Harvard University Press.
115. Latour, B. 1987. Science in Action: How to Follow Scientists and Engineers Through Society. Milton Keynes: Open University Press.
116. Latour, B. 2004. Why has critique run out of steam? From matters of fact to matters of concern. Critical Inquiry, 30(2), 225-48.
117. Latour, B. 2005. Reassembling the Social: An Introduction to Actor-Network Theory. Oxford: Oxford University Press.
118. Law, J. 1999. After ANT: Complexity, naming and topology, in Actor Network Theory and After, edited by J. Law and J. Hassard. Oxford, UK: Blackwell, 1-14.
119. Law, J. 2004. After Method: Mess in Social Science Research. London and New York: Routledge.
120. Lenson, D. 1995. On Drugs. Minneapolis, MN and London: University of Minnesota Press.
121. Lenton, E., Fraser, S., Moore, D. and Treloar, C. 2011. Hepatitis C, love and intimacy: Beyond the ‘anomalous body’. Drugs: Education, Prevention and Policy, 18(3), 228-36.
122. Leshner, A. 1999. The next generation of drug abuse research. NIDA Notes [Online], 14(1). Available at http://www.nida.nih.gov/nida_notes/nnvol14n1/DirRepVol14N1.html [accessed: 16 April 2009].
123. Levine, H. 1978. The discovery of addiction: Changing conceptions of habitual drunkenness in America. Journal of Studies on Alcohol, 39(1), 143-74.
124. Lindsay, K.L. 1997. Therapy of hepatitis C: Overview. Hepatology, 26(3), 71S-7S.
125. Lupton, D. 1992. Discourse analysis: A new methodology for understanding the ideologies of health and illness. Australian Journal of Public Health, 16(2), 145-50.
126. Lupton, D. 1995. The Imperative of Health. London: Sage.
127. Lupton, D. 1997. Foucault and the medicalisation critique, in Foucault, Health and Medicine, edited by A. Petersen and R. Bunton. London and New York: Routledge, 94-110.
128. Macdonald, G. and Bunton, R. 1992. Health promotion: Disciplinary developments, in Health Promotion: Disciplines, Diversity, and Developments, 2nd edition, edited by R. Bunton and G. Macdonald. London: Routledge, 9-27.
129. Maddrey, W.C. 2001. Update in hepatology. Annals of Internal Medicine Update Series, 134, 216-23.
130. Majer, M., Welberg, L.A., Capuron, L., Pagnoni, G., Raison, C.L., and Miller, A.H. 2008. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain, Behavior and Immunity, 22, 870-80.
131. Manns, M.P., McHutchison, J.G., Gordon, S.C., Rustgi, VK., Shiftman, M., Reindollar, R., Goodman, Z.D., Koury, K., Ling, M., Albrecht, J.K. 2001. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet, 358, 958-65.
132. Martell, M.E.A. 1992. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. Journal of Virology, 66(5), 3225-9.
133. Más, A., López-Galíndez, C., Cacho, I., Gómez, J. and Martínez, M.A. 2010. Unfinished stories on viral quasispecies and Darwinian views of evolution. Journal of Molecular Biology, 397, 865-77.
134. McHutchison, J.G. and Fried, M.W. 2003. Current therapy for hepatitis C: Pegylated interferon and ribavirin. Clinics in Liver Disease, 7(1), 149-61.
135. McNay, L. 1991. The Foucauldian body and the exclusion of experience. Hypatia, 6(3), 125-39.
136. Mol, A. 1999. Ontological politics: A word and some questions, in Actor Network Theory and After, edited by J. Law and J. Hassard. Oxford: Blackwell, 74-89.
137. Mol, A. 2002. The Body Multiple: Ontology in Medical Practice. Durham, NC: Duke University Press.
138. Mol, A. and Law, J. 2002. Complexities: An introduction, in Complexities: Social Studies of Knowledge Practices, edited by J. Law and A. Mol. Durham, NC: Duke University Press, 1-22.
139. Moore, D. and Fraser, S. 2006. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine, 62, 3035-47.
140. Moradpour, D., Cerny, A., Heim, M.H. and Blum, H.E. 2001. Hepatitis C: An update. Swiss Medical Weekly, 131, 291-8.
141. National Centre in HIV Epidemiology and Clinical Research (NCHECR) 2005. Annual Surveillance Report: HIV/AIDS, Viral Hepatitis and Sexually Transmitted Infections in Australia. Sydney: NCHECR, University of NSW.
142. National Centre in HIV Epidemiology and Clinical Research (NCHECR). 2008a. HIV/AIDS, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report. Sydney: NCHECR, University of NSW.
143. National Centre in HIV Epidemiology and Clinical Research (NCHECR) 2008b. Australian NSP Survey National Data Report 2003-2007. Sydney: NCHECR, UNSW.
144. Nettleton, S. 1995. The Sociology of Health and Illness, 1st edition. Cambridge: Polity Press.
145. Nettleton, S. 1996. Women and the new paradigm of health and medicine. Critical Social Policy, 16, 33-53.
146. New South Wales Health. 2008. Review of Hepatitis C Treatment and Care Services, New South Wales: NSW Health.
147. Novas, C. and Rose, N. 2000. Genetic risk and the birth of the somatic individual. Economy & Society, 29(4), 485-513.
148. O’Malley, P, Weir, L. and Shearing, C. 1997. Governmentality, criticism, politics. Economy and Society, 26(4), 501-17.
149. Orsini, M. 2002. The politics of naming, blaming and claiming: HIV, hepatitis C and the emergence of blood tainted activism in Canada. Canadian Journal of Political Science, 35(3), 475-98.
150. Orsini, M. 2008. Hepatitis C and the dawn of biological citizenship: Unravelling the policy implications, in Contesting Illness: Processes and Practices, edited by P. Moss and K. Teghtsoonian. Toronto: University of Toronto Press.
151. Oudshoorn, N. 1994. Beyond the Natural Body: An Archeology of Sex Hormones. London: Routledge.
152. Patterson, B., Backmund, M., Hirsch, G. and Yim, C. 2007. The depiction of stigmatization in research about hepatitis C. International Journal of Drug Policy, 18, 364-73.
153. Patton, P 1989. Taylor and Foucault on power and freedom. Political Studies, 37, 260-76.
154. Paul, N. 2005. Living with Hepatitis C for Dummies. Hoboken, NJ: Wiley.
155. Pearlman, B.L. 2004a. Hepatitis C infection: A clinical review. Southern Medical Journal, 97(4), 365-73.
156. Pearlman, B.L. 2004b. Hepatitis C treatment update. American Journal of Medicine, 117, 344-52.
157. Pérez, V. 2007. Review article: Viral hepatitis: Historical perspectives from the 20th to the 21st century. Archives ofMedicalResearch, 38(6), 593-605.
158. Petersen, A. 1997a. The new morality: Public health and personal conduct, in Foucault: The Legacy, edited by C. O’Farrell. Kelvin Grove: Queensland University of Technology, 696-706.
159. Petersen, A. 1997b. Risk, governance and the new public health, in Foucault Health and Medicine, edited by A. Petersen and R. Bunton. London: Routledge, 189-206.
160. Petersen, A. and Lupton, D. 1996. The New Public Health: Health and Self in the Age of Risk. St Leonards: Allen & Unwin.
161. Plagemann, P. 1991. Hepatitis C virus: Brief review. Archives of Virology, 120, 160-80.
162. Porter, R. 1997. The Greatest Benefit to Mankind: A Medical History of Humanity. London: HarperCollins.
163. Power, C. and Rasko, J.E.J. 2008. Whither Prometheus’ liver? Greek myth and the science of regeneration. Annals of Internal Medicine, 149, 421-6.
164. Pugh, J. 2008. Hepatitis C and the Australian news media: A case of ‘bad blood’. Continuum, 22(3), 385-94.
165. Purcell, R.H. 1994. Hepatitis viruses: Changing patterns of human disease. Proceedings of the National Academy of Sciences of the United States of America, 91(7), 2401-6.
166. Purcell, R.H. 1997. The hepatitis C virus: Overview. Hepatology, 11s-14s.
167. Purcell, R.H. 2006. Hepatitis C virus: Historical perspective and current concept. FEMSMicrobiology Reviews, 14(3), 181-91.
168. Queensland Health. 2005. Injecting + Infections. QLD: Exchange Supplies.
169. Rabinow, P. and Rose, N. 2006. Biopower today. Biosocieties, 1, 195-217.
170. Raison, C.L., Demetrashvili, M., Capuron, L. and Miller, A.H. 2005. Neuropsychiatric adverse effects of interferon-alpha: Recognition and management. CNS Drugs, 19(2), 105-23.
171. Rhodes, T. and Treloar, C. 2008. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction, 103, 1593-603.
172. Ricoeur, P. 1977. The Rule of Metaphor: Multi-disciplinary Studies of the Creation of Meaning in Language. Toronto: University of Toronto Press.
173. Rimke, H. 2000. Governing citizens through self-help literature. Cultural Studies, 14(1), 61-78.
174. Roberts, C., valentine, k. and Fraser, S. 2009. Rationalities and non-rationalities in clinical encounters. Science as Culture, 18(2), 165-81.
175. Rose, N. 1999. Powers of Freedom: Reframing Political Thought. Cambridge: Cambridge University Press.
176. Rose, N. 2007a. The Politics of Life Itself Princeton: Princeton University Press.
177. Rose, N. 2007b. Beyond medicalisation. Lancet. 369(9562), 700-702.
178. Rosenberg, C.E. 1992. Explaining Epidemics and Other Studies in the History of Medicine. Cambridge: Cambridge University Press.
179. Rosenberg, C.E. 2002. The tyranny of diagnosis: Specific entities an individual experience. The Milbank Quarterly, 80(2), 237-60.
180. Saleh, D.A., Shebl, F.M., El-Kamary, S.S., Magder, L.S., Allam, A., Abdel-Hamid, M., Mikhail, N., Hashem, M., Sharaf, S., Stoszek, S.K. and Strickland, G.T. 2010. Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children. Transactions of the Royal Society of Tropical Medicine and Hygiene. 104(5), 357-63.
181. Sarbah, S.A. and Younossi, Z.M. 2000. Hepatitis C: An update on the silent epidemic, clinical reviews. Journal of Clinical Gastroenterology, 30(2), 12543.
182. Sarrazin, C. 2004. Diagnosis of hepatitis C: Update 2004. Journal of Gastroenterology and Hepatology, 19, S88-S93.
183. Scott, S. 2006. The medicalisation of shyness: From social misfits to social fitness. Sociology of Health & Illness. 28(2), 133-53.
184. Seddon, T. 2007. Drugs and freedom. Addiction Research and Theory, 15(4), 33342.
185. Sedgwick, E. 1993. Epidemics of the will, in Tendencies, edited by E. Sedgwick. London: Routledge.
186. Seear, K. 2009a. “Nobody really knows what it is or how to treat it’: Why women with endometriosis do not comply with healthcare advice.’ Health, Risk and Society, 11(4), 367-85.
187. Seear, K. 2009b. “Standing up to the beast’: Contradictory notions of control, un/certainty and risk in the endometriosis self-help literature.’ Critical Public Health, 19(1), 45-58.
188. Seear, K. and Fraser, S. 2010. “The sorry addict’: Ben Cousins and the construction of drug use in elite sport.’ Health Sociology Review, 19(2), 176-91.
189. Seear, K., Fraser, S. and Lenton, E. 2010. Guilty or angry? The politics of emotion in accounts of hepatitis C transmission. Contemporary Drug Problems, 37(4), 619-38.
190. Sharara, A.I., Hunt, C.M. and Hamilton, J.D. 1996. Update: Hepatitis C. Annals of Internal Medicine, 125, 658-68.
191. Shepard, C., Finelli, L. and Alter, M. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infectious Diseases, 5, 558-67.
192. Sherlock, S. 1996. Hepatitis C virus: A historical perspective. Digestive Diseases and Sciences, 41(12), 3S-5S.
193. Smith, B.C., Strasser, S.I. and Desmond, P.V. 1995. Current perspectives in hepatitis C. Australian and New Zealand Journal of Medicine, 25, 350-57.
194. St John, T. and Sandt, L. 2005. The hepatitis C crisis. Ethnicity and Disease, 15(S2), 52-7.
195. Star, S.L. 1991. Power, technology and the phenomenology of conventions: On being allergic to onions, in A Sociology of Monsters: Essays on Power, Technology and Domination, edited by J. Law. London: Routledge, 26-56.
196. Stenson, K. 1998. Beyond histories of the present. Economy and Society, 27(4), 333-52.
197. Stoové, M.A., Gifford, S.M. and Dore, G.J. 2005. The impact of injecting drug use status on hepatitis C-related referral and treatment. Drug and Alcohol Dependence, 77, 81-6.
198. Tacconelli, E. 2009. Living Confidently with HIV. Gloucester: Blue Stallion Publications.
199. Tatchell, P. 1997. Fighting Back Against HIV. London and New York: Continuum.
200. Taylor, C. 1984. Foucault on freedom and truth. Political Theory, 12(2), 152-83.
201. Tomes, N. 2007. Patient empowerment and the dilemmas of late-modern medicalisation. Lancet, 369(9562), 698-700.
202. Treichler, P. 1999. How to Have Theory in an Epidemic: Cultural Chronicles of AIDS. Durham, NC: Duke University Press.
203. Treloar, C. and Fraser, S. 2004. Hepatitis C, blood and models of the body: New directions for public health. Critical Public Health, 14, 377-89.
204. Treloar, C. and Rhodes, T. 2009. The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research, 19(9), 1321-34.
205. Turner, B.S. 1995. Medical Power and Social Knowledge, 2nd edition. London: Sage.
206. Valverde, M. 1998. Diseases of the Will: Alcohol and the Dilemmas of Freedom, Cambridge: Cambridge University Press.
207. Vickerman, P., Miners, A. and Williams, J. 2008. Assessing the Cost-effectiveness of Interventions Linked to Needle and Syringe Programmes for Injecting Drug Users: An Economic Modeling Report. London: National Institute for Health and Clinical Excellence.
208. Victorian Government Department of Human and Community Services. 1995. Hepatitis C: The Facts. Melbourne: Health and Community Services Promotion Unit.
209. Victorian Government Department of Human and Community Services. 1996. Hepatitis C: The Facts. Melbourne: Infectious Disease Unit.
210. Volk, M.L., Tocco, R., Saini, S. and Lok, A.S.F. 2009. Public health impact of antiviral therapy for hepatitis C in the United States, Hepatology, 50(6), 1750-1755.
211. Waldby, C. 1996. AIDS and the Body Politic: Biomedicine and Sexual Difference. London: Routledge.
212. Walker, M.A. 1999. Hepatitis C virus: an overview of current approaches and progress. Drug Discovery Today, 4(11), 518-29.
213. Walker, M.P., Appleby, T.C., Zhong, W., Lau, J.Y. and Hong, Z. 2003. Review: Hepatitis C virus therapies: Current treatments, targets and future perspectives. Antiviral Chemistry & Chemotherapy, 14, 1-21.
214. Walsh, K. and Alexander, G.J.M. 2001. Update on chronic viral hepatitis. Postgraduate Medicine, 77, 498-505.
215. Washington, H. 2000. Living Healthy with Hepatitis C. New York: Random House.
216. West, R. 2001. Theories of addiction. Addiction, 96, 3-13.
217. White, W.L. 1998. Slaying the Dragon: The History of Addiction Treatment and Recovery in America. Bloomington: Chestnut Health Systems.
218. White, W.L. 2001. Addiction disease concept: Advocates and critics. Counselor, February.
219. Woerz, I., Lohmann, V and Bartenschlager, R. 2009. Review: Hepatitis C virus replicons: Dinosaurs still in business? Journal of Viral Hepatitis, 16, 1-9.
220. Wong, W. and Terrault, N. 2005. Reviews: Update on chronic hepatitis C. Clinical Gastroenterology and Hepatology, 3, 507-20.
221. Yu, M.L., Dai, C.Y., Lin, Z.Y., Lee, L.P., Hou, N.J., Hsieh, M.Y., Chen, S.C., Hsieh, M.Y., Wang, L.Y., Chang, W.Y. and Chuang, W.L. 2006. A randomized trial of 24-vs. 48-week courses of PEG interferon alpha-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: A pilot study in Taiwan. Liver International, 26(1), 73-81.
222. Zickmund, S., Bryce, C., Blasiole, J., Shinkunas, L., LaBrecque, D. and Arnold, R. 2006. Majority of patients with hepatitis C express physical, mental, and social difficulties with antiviral treatment. European Journal of Gastroenterology and Hepatology, 18(4), 381-8.
223. Zola, I.K. 1972. Medicine as an institution of social control. Sociological Review, 20, 487-504.
224. Zou, S., Forrester, L. and Giulivi, A. 2003. Hepatitis C update. Canadian Journal of Public Health, 94(2), 127-9.